Tower Research Capital (TRC)’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $122K | Buy |
4,868
+3,515
| +260% | +$83.2K | ﹤0.01% | 2034 |
|
|
2025
Q4 | $35.6K | Sell |
1,353
-9,948
| -88% | -$217K | ﹤0.01% | 2685 |
|
|
2025
Q3 | $193K | Buy |
11,301
+6,354
| +128% | +$90.9K | 0.01% | 1490 |
|
|
2025
Q2 | $62.1K | Buy |
4,947
+1,131
| +30% | +$13.5K | ﹤0.01% | 2786 |
|
|
2025
Q1 | $45.4K | Sell |
3,816
-5,888
| -61% | -$80.3K | ﹤0.01% | 2289 |
|
|
2024
Q4 | $142K | Buy |
9,704
+7,518
| +344% | +$105K | ﹤0.01% | 1937 |
|
|
2024
Q3 | $27.4K | Sell |
2,186
-8,068
| -79% | -$87.9K | ﹤0.01% | 3063 |
|
|
2024
Q2 | $87.3K | Buy |
10,254
+6,707
| +189% | +$59.7K | ﹤0.01% | 2673 |
|
|
2024
Q1 | $37.3K | Sell |
3,547
-13,545
| -79% | -$150K | ﹤0.01% | 2475 |
|
|
2023
Q4 | $178K | Buy |
17,092
+14,612
| +589% | +$116K | ﹤0.01% | 2198 |
|
|
2023
Q3 | $15.7K | Buy |
2,480
+643
| +35% | +$4.75K | ﹤0.01% | 3600 |
|
|
2023
Q2 | $15.9K | Sell |
1,837
-17,438
| -90% | -$156K | ﹤0.01% | 3603 |
|
|
2023
Q1 | $174K | Buy |
19,275
+15,999
| +488% | +$140K | 0.01% | 1447 |
|
|
2022
Q4 | $26K | Buy |
+3,276
| New | +$23K | ﹤0.01% | 2897 |
|
|
2022
Q3 | – | Sell |
-5,184
| Closed | -$27K | – | 6559 |
|
|
2022
Q2 | $27K | Buy |
5,184
+760
| +17% | +$4.6K | ﹤0.01% | 3488 |
|
|
2022
Q1 | $29K | Sell |
4,424
-9,149
| -67% | -$81.5K | ﹤0.01% | 3202 |
|
|
2021
Q4 | $222K | Buy |
13,573
+5,742
| +73% | +$120K | ﹤0.01% | 1688 |
|
|
2021
Q3 | $227K | Buy |
7,831
+7,695
| +5,658% | +$256K | 0.01% | 1702 |
|
|
2021
Q2 | $5K | Sell |
136
-7,865
| -98% | -$250K | ﹤0.01% | 4745 |
|
|
2021
Q1 | $253K | Buy |
+8,001
| New | +$325K | ﹤0.01% | 1805 |
|
|
2020
Q3 | – | Sell |
-542
| Closed | -$20K | – | 5148 |
|
|
2020
Q2 | $20K | Buy |
+542
| New | +$20K | ﹤0.01% | 3691 |
|
|
2019
Q4 | – | Sell |
-586
| Closed | -$15K | – | 4492 |
|
|
2019
Q3 | $15K | Buy |
+586
| New | +$14.7K | ﹤0.01% | 2688 |
|
|
2018
Q4 | – | Sell |
-293
| Closed | -$5K | – | 4447 |
|
|
2018
Q3 | $5K | Sell |
293
-927
| -76% | -$13.3K | ﹤0.01% | 3145 |
|
|
2018
Q2 | $18K | Buy |
1,220
+908
| +291% | +$14.1K | ﹤0.01% | 2503 |
|
|
2018
Q1 | $4K | Sell |
312
-1,454
| -82% | -$15.7K | ﹤0.01% | 2813 |
|
|
2017
Q4 | $14K | Buy |
1,766
+1,566
| +783% | +$12.9K | ﹤0.01% | 2343 |
|
|
2017
Q3 | $2K | Sell |
200
-200
| -50% | -$1.55K | ﹤0.01% | 3602 |
|
|
2017
Q2 | $3K | Buy |
+400
| New | +$4.48K | ﹤0.01% | 2253 |
|
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
Tower Research Capital (TRC)'s ZYME Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Zymeworks (ZYME) stake by 260% in Q1 2026, buying an estimated $83.2K and bringing the position to 4,868 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2034.
Tower Research Capital (TRC) first reported a position in ZYME in Q2 2017 and has held it in 28 quarters since. The position peaked at $253K in Q1 2021. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Tower Research Capital (TRC) held 4,868 shares of Zymeworks worth $122K as of Q1 2026.
- Tower Research Capital (TRC) bought 3,515 Zymeworks shares in Q1 2026, an estimated $83.2K.
- Zymeworks made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2034 holding.
- Tower Research Capital (TRC) first reported a position in Zymeworks in Q2 2017 and has held it in 28 quarters since.
- Tower Research Capital (TRC)'s Zymeworks position peaked at $253K in Q1 2021.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.